Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system.
A vast literature exists on the biology of blood formation and regeneration under experimental and clinical conditions. The field of hematopoiesis was recently advanced by the capacity to purify to homogeneity primitive hematopoietic stem and progenitor cells. Isolation of cells at defined maturational stages has enhanced the understanding of the fundamental nature of stem cells, including how cell fate decisions are made, and this understanding is relevant to the development of other normal as well as malignant tissues. This review updates the basic biology of hematopoietic stem cells (HSC) and progenitors, the evolving use of purified HSC as grafts for clinical hematopoietic cell transplantation (HCT) including immune tolerance induction, and the application of HSC biology to other stem cell fields.
Shizuru
Judith A
JA
Division of Blood and Marrow Transplantation, Stanford University Medical Center, California 94305, USA. jshizuru@stanford.edu
Negrin
Robert S
RS
Weissman
Irving L
IL
D000818:Animals; D018952:Antigens, CD34 / Q000032:analysis; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy; D002454:Cell Differentiation / Q000502:physiology; D002469:Cell Separation; D002471:Cell Transformation, Neoplastic / Q000378:metabolism; D006410:Hematopoiesis / Q000502:physiology*; D006412:Hematopoietic Stem Cells / Q000502:physiology*; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D008208:Lymphatic System / Q000502:physiology*; D039902:Multipotent Stem Cells / Q000502:physiology; D012038:Regeneration / Q000502:physiology*; D014184:Transplantation, Homologous
D018952:Antigens, CD34